Davion Healthcare confirms 7.88M shares held by Cede

The stated balance reflects Cede & Co.'s registered nominee position, not shares available for sale or lending, short interest, or failures to deliver.

Available on EDGAR 11/09/2026 - 02:18 PM EST Accepted by SEC EDGAR 11/09/2026 - 02:18 PM EST Learn about SEC filing dates

Rhea-AI Filing Summary

Davion Healthcare Plc confirmed that, according to records from transfer agent Vstock Transfer LLC, 7,877,590 ordinary shares were registered in the name of Cede & Co. as of November 6, 2026. Cede & Co. holds them as registered nominee for DTC participants on behalf of underlying beneficial owners. The balance is not a measure of shares available for sale or lending, short interest, or failures to deliver.

Key Figures

Ordinary shares registered in Cede & Co.'s name: 7,877,590 ordinary shares

1 metrics

Ordinary shares registered in Cede & Co.'s name 7,877,590 ordinary shares As of November 6, 2026

Key Terms

registered nominee, beneficial owners, failures to deliver

3 terms

registered nominee technical

"holds these shares as registered nominee for DTC participants"

beneficial owners financial

"on behalf of underlying beneficial owners"

Beneficial owners are the people or entities that actually enjoy the economic benefits and control of shares or other assets, even when legal title is held by someone else such as a broker, custodian or trustee. Investors pay attention because beneficial owners hold the real voting power, receive dividends and can influence strategy and takeover outcomes — like the driver of a car who uses and maintains it while the bank holds the title — so disclosure shows who truly controls and benefits.

failures to deliver financial

"short interest, or failures to deliver"

A failure to deliver occurs when a seller does not deliver the shares or securities they sold by the required settlement date, leaving the buyer unpaid or without the stock. It matters to investors because persistent or large failures can signal settlement breakdowns, stock borrowing shortages, or unusual selling activity—similar to a buyer paying for goods that never arrive—and can increase short-term price volatility and regulatory scrutiny.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many DAVI shares were registered to Cede & Co.?

DAVI reported that 7,877,590 ordinary shares were registered in Cede & Co.'s name as of November 6, 2026, according to records provided by transfer agent Vstock Transfer LLC. Cede & Co. holds the shares as nominee for DTC participants on behalf of underlying beneficial owners.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 6-K: How Foreign Companies Report to the SEC →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 6-K

REPORT OF FOREIGN PRIVATE ISSUER

PURSUANT TO RULE 13a-16 OR 15d-16 UNDER

THE SECURITIES EXCHANGE ACT OF 1934

For the Month of November 2026

Commission File Number 001-42981

DAVION HEALTHCARE PLC

(Translation of registrant’s name into English)

Unit A, West Cork Business Park

Clonakilty

County Cork

P85 FV48

Ireland

(Address of principal executive office)

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

Form 20-F ☒ Form 40-F ☐

ITEM 7.01 REGULATION FD DISCLOSURE

In response to shareholder enquiries, Davion Healthcare Plc confirms that, according to records provided by its transfer agent, Vstock Transfer LLC, 7,877,590 ordinary shares were registered in the name of Cede & Co., the nominee of The Depository Trust Company (DTC), as of November 6, 2026.

Cede & Co. holds these shares as registered nominee for DTC participants on behalf of underlying beneficial owners. This figure represents a registration balance at that date and does not constitute a measure of shares available for sale or lending, short interest, or failures to deliver.”

2

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

	DAVION HEALTHCARE PLC
	By:	/s/ Glenn Williams
		Name: Glenn Williams Title: Chief Executive officer

Date: November 9^th, 2026

3